Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)
J. Clin. Oncol 2019 Dec 05;[EPub Ahead of Print], A Lluch, CH Barrios, L Torrecillas, M Ruiz-Borrego, J Bines, J Segalla, Á Guerrero-Zotano, JA García-Sáenz, R Torres, J de la Haba, E García-Martínez, HL Gómez, A Llombart, JS Bofill, JM Baena-Cañada, A Barnadas, L Calvo, L Pérez-Michel, M Ramos, I Fernández, Á Rodríguez-Lescure, J Cárdenas, J Vinholes, E Martínez de Dueñas, MJ Godes, MA Seguí, A Antón, P López-Álvarez, J Moncayo, G Amorim, E Villar, S Reyes, C Sampaio, B Cardemil, MJ Escudero, S Bezares, E Carrasco, M MartínFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.